Tag: GCP compliance

Missing Data in Clinical Trials: Designing Strategies, Not Afterthoughts

Posted on By digi

Missing Data in Clinical Trials: Designing Strategies, Not Afterthoughts Missing Data in Clinical Trials: Designing Strategies, Not Afterthoughts Missing data is a pervasive issue in clinical trials that can significantly impact the integrity and validity of study results. With an increasing emphasis on high-quality and reliable data, it is essential for clinical operations, regulatory affairs,…

Read More “Missing Data in Clinical Trials: Designing Strategies, Not Afterthoughts” »

Missing Data Strategies & Sensitivity Analyses

Future Trends: AI, Machine Learning and Advanced Analytics in RBM

Posted on By digi

Future Trends: AI, Machine Learning and Advanced Analytics in RBM Future Trends: AI, Machine Learning and Advanced Analytics in Risk-Based Monitoring (RBM) Risk-Based Monitoring (RBM) in clinical trials is rapidly evolving, driven by the integration of advanced technologies such as artificial intelligence (AI) and machine learning (ML). This guide aims to provide clinical operations, regulatory…

Read More “Future Trends: AI, Machine Learning and Advanced Analytics in RBM” »

Technology Enablement for RBM

Working With Vendors to Co-Develop RBM Technology Roadmaps

Posted on By digi

Working With Vendors to Co-Develop RBM Technology Roadmaps Working With Vendors to Co-Develop RBM Technology Roadmaps Introduction to Risk-Based Monitoring in Clinical Trials The implementation of Risk-Based Monitoring (RBM) in clinical trials stipulates a systematic approach to overseeing trials with the aim of enhancing data integrity and participant safety while optimizing resources. This practice is…

Read More “Working With Vendors to Co-Develop RBM Technology Roadmaps” »

Technology Enablement for RBM

Integrating Reconciliation Outputs With Data Cleaning and Lock Readiness

Posted on By digi

Integrating Reconciliation Outputs With Data Cleaning and Lock Readiness Integrating Reconciliation Outputs With Data Cleaning and Lock Readiness In the landscape of clinical trials, the integration of data reconciliation outputs with comprehensive data cleaning processes is critical to achieving lock readiness. This ensures that datasets are not only complete and accurate but also compliant with…

Read More “Integrating Reconciliation Outputs With Data Cleaning and Lock Readiness” »

Data Reconciliation (SAE, PK/PD, IVRS)

Inspection Expectations for Evidence of Robust Reconciliation Processes

Posted on By digi

Inspection Expectations for Evidence of Robust Reconciliation Processes Inspection Expectations for Evidence of Robust Reconciliation Processes Clinical trials are integral to the advancement of medical knowledge and therapeutic practices, particularly in fields such as ovarian cancer clinical trials. As clinical operations, regulatory affairs, and medical affairs professionals engage in these processes, it is crucial to…

Read More “Inspection Expectations for Evidence of Robust Reconciliation Processes” »

Data Reconciliation (SAE, PK/PD, IVRS)

Common Mistakes in Estimand Definition and How to Avoid Them

Posted on By digi

Common Mistakes in Estimand Definition and How to Avoid Them Common Mistakes in Estimand Definition and How to Avoid Them The definition of an estimand is a critical element in the design and analysis of clinical trials. An estimand specifies what effect of a treatment is of interest and under what conditions it is estimated….

Read More “Common Mistakes in Estimand Definition and How to Avoid Them” »

Estimands & Handling Intercurrent Events

Planning for Change Management When Deploying RBM Platforms

Posted on By digi

Planning for Change Management When Deploying RBM Platforms Planning for Change Management When Deploying RBM Platforms In the complex landscape of clinical trials, especially with the evolving methodologies that include risk-based monitoring (RBM), managing change effectively is crucial. This comprehensive guide provides a step-by-step tutorial for clinical operations, regulatory affairs, and medical affairs professionals on…

Read More “Planning for Change Management When Deploying RBM Platforms” »

Technology Enablement for RBM

KPIs to Measure RBM Technology Adoption and Impact

Posted on By digi

KPIs to Measure RBM Technology Adoption and Impact KPIs to Measure RBM Technology Adoption and Impact As the landscape of clinical trials continues to evolve, the adoption of Risk-Based Monitoring (RBM) technology is becoming increasingly vital. This article provides a comprehensive, step-by-step tutorial aiming to equip clinical operations, regulatory affairs, and medical affairs professionals in…

Read More “KPIs to Measure RBM Technology Adoption and Impact” »

Technology Enablement for RBM

Automation Opportunities in Data Reconciliation Workflows

Posted on By digi

Automation Opportunities in Data Reconciliation Workflows Data reconciliation is a critical component of clinical trials, serving to ensure the accuracy, integrity, and reliability of data collected throughout the trial process. In an environment regulated by organizations such as the FDA, EMA, and MHRA, it is essential to adhere to stringent requirements while optimizing workflows. This…

Read More “Automation Opportunities in Data Reconciliation Workflows” »

Data Reconciliation (SAE, PK/PD, IVRS)

Training Study Teams on Reconciliation Priorities and Techniques

Posted on By digi

Training Study Teams on Reconciliation Priorities and Techniques Introduction to Data Reconciliation in Clinical Trials Data reconciliation is a fundamental process in clinical trials, ensuring the accuracy and integrity of the data collected. In the context of good lab clinical trials, data reconciliation involves comparing and aligning data from various sources to identify discrepancies and…

Read More “Training Study Teams on Reconciliation Priorities and Techniques” »

Data Reconciliation (SAE, PK/PD, IVRS)